Subglottic squamous cell carcinoma in Denmark 1971–2015 – a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group

BIGART 2019 – adapting to the future

“…While the technical abilities for advanced treatment delivery currently dominates the field of radiation oncology, the importance of utilizing and understanding clinical radiobiology gradually returns to the focus area. This takes place partly through well designed studies where predictive parameters are being applied in order to select the right patients for the right treatment [76][77][78][79][80][81][82]. This happens through analyses of risk factors associated with treatment related morbidity, such as cardiovascular problems or risk of radiation induced secondary cancer, and also by focusing on variation in tumor radiosensitivity, such as the influence of human papillomavirus (HPV) positivity related to the irradiation treatment of squamous cell carcinomas [83,84].…”